國立高雄大學圖資館 |

Language: English

Back

Early phase cancer immunotherapy

Kurzrock, Razelle.

Early phase cancer immunotherapy

Record Type:	Electronic resources : Monograph/item
Title/Author:	Early phase cancer immunotherapyedited by Sandip Pravin Patel, Razelle Kurzrock.
other author:	Patel, Sandip Pravin.
Published:	Cham :Springer International Publishing :2018.
Description:	xi, 331 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
Subject:	CancerImmunotherapy.
Online resource:	http://dx.doi.org/10.1007/978-3-319-63757-0
ISBN:	9783319637570$q(electronic bk.)

Early phase cancer immunotherapy
Early phase cancer immunotherapy[electronic resource] /edited by Sandip Pravin Patel, Razelle Kurzrock. - Cham :Springer International Publishing :2018. - xi, 331 p. :ill., digital ;24 cm. - Current cancer research,2199-2584. - Current cancer research..

Chapter 1 Primer on Cancer Immunotherapy and the Targeting of Native Proteins -- Chapter 2 Pharmacokinetics and Pharmacodynamics of Immunotherapy -- Chapter 3 Immunotherapeutic Biomarkers and Selection Strategies -- Chapter 4 Radiographic Evaluation of Immunotherapy -- Chapter 5 Cellular Therapy -- Chapter 6 Combinatorial Checkpoint Blockade Immunotherapy and Radiation -- Chapter 7 Early Phase Cancer Immunotherapy -- Chapter 8 Immune Checkpoint Combinations with Inflammatory Pathway Modulators -- Chapter 9 Combinations of Genomically and Immune-Targeted Therapies in Early-Phase Clinical Trials -- Chapter 10 Thoracic Immunotherapy.

This volume, a state-of-the-art review of early phase clinical trials for cancer immunotherapy, discusses biomarker selection, combinatorial strategies and their safety or toxicity, determination of Phase 2 dosing, endpoints in the setting of radiographic pseudoprogression, histology selection, and novel immunotherapeutics as they relate to early phase cancer immunotherapy.

ISBN: 9783319637570$q(electronic bk.)

Standard No.: 10.1007/978-3-319-63757-0doiSubjects--Topical Terms:

201873
Cancer
--Immunotherapy.

LC Class. No.: RC271.I45

Dewey Class. No.: 616.99406

Early phase cancer immunotherapy
LDR:01996nmm a2200325 a 4500 001 529508
003 DE-He213
005 20180726092502.0
006 m d
007 cr nn 008maaau
008 181105s2018 gw s 0 eng d
020 $a 9783319637570$q(electronic bk.)
020 $a 9783319637563$q(paper)
024 7 $a 10.1007/978-3-319-63757-0 $2 doi
035 $a 978-3-319-63757-0
040 $a GP $c GP
041 0 $a eng
050 4 $a RC271.I45
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
082 0 4 $a 616.99406 $2 23
090 $a RC271.I45 $b E12 2018
245 0 0 $a Early phase cancer immunotherapy $h [electronic resource] / $c edited by Sandip Pravin Patel, Razelle Kurzrock.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2018.
300 $a xi, 331 p. : $b ill., digital ; $c 24 cm.
490 1 $a Current cancer research, $x 2199-2584
505 0 $a Chapter 1 Primer on Cancer Immunotherapy and the Targeting of Native Proteins -- Chapter 2 Pharmacokinetics and Pharmacodynamics of Immunotherapy -- Chapter 3 Immunotherapeutic Biomarkers and Selection Strategies -- Chapter 4 Radiographic Evaluation of Immunotherapy -- Chapter 5 Cellular Therapy -- Chapter 6 Combinatorial Checkpoint Blockade Immunotherapy and Radiation -- Chapter 7 Early Phase Cancer Immunotherapy -- Chapter 8 Immune Checkpoint Combinations with Inflammatory Pathway Modulators -- Chapter 9 Combinations of Genomically and Immune-Targeted Therapies in Early-Phase Clinical Trials -- Chapter 10 Thoracic Immunotherapy.
520 $a This volume, a state-of-the-art review of early phase clinical trials for cancer immunotherapy, discusses biomarker selection, combinatorial strategies and their safety or toxicity, determination of Phase 2 dosing, endpoints in the setting of radiographic pseudoprogression, histology selection, and novel immunotherapeutics as they relate to early phase cancer immunotherapy.
650 0 $a Cancer $x Immunotherapy. $3 201873
650 1 4 $a Biomedicine. $3 273648
650 2 4 $a Cancer Research. $3 273660
700 1 $a Patel, Sandip Pravin. $3 802662
700 1 $a Kurzrock, Razelle. $3 277263
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
830 0 $a Current cancer research. $3 558904
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-63757-0
950 $a Medicine (Springer-11650)